Genetic and pharmacological evidence for more than one human steroid 5α-reductase

The enzyme steroid 5α-reductase catalyzes the conversion of testosterone into the more potent androgen, dihydrotestosterone, and impairment of this reaction causes a form of male pseudohermaphroditism in which genetic males differentiate predominantly as phenotypic females. We previously isolated cDNA clones that encode a human steroid 5α-reductase enzyme. Here, we report molecular and genetic studies demonstrating that the gene encoding this cDN A is normal in subjects with the genetic disease steroid 5α-reductase deficiency. We further show that in contrast to the major steroid 5a-reductase in the prostate and cultured skin fibroblasts, the cDNA-encoded enzyme exhibits a neutral to basic pH optima and is much less sensitive to inhibition by the 4-aza steroid, finasteride (MK-906). The results provide genetic, biochemical, and pharmacological support for the existence of at least two steroid 5α-reductase isozymes in man.